Center for Ethics Professor Leonard Fleck discusses cancer drug resistance and the question “How should we fairly distribute access to needed health care for an enormous range of health care needs when we have only limited resources (money) to meet virtually unlimited health care needs (cancer and everything else)?”
The article was published in the Journal of Personalized Medicine 2013, Vol. 3, No. 3, and is available to read here.
MSU Bioethics 